Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

NeuroSense Therapeutics Ltd.

NAS: NRSN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
NeuroSense Therapeutics Ltd.

Before the Bell

NRSN
/zigman2/quotes/230850337/composite

$

1.05

Change

+0.03 +2.44%

Volume

Volume 172

Nov 30, 2023, 5:29 a.m.

Quotes are delayed by 20 min

/zigman2/quotes/230850337/composite

Previous close

$ 1.03

$ 1.03

Change

+0.14 +15.79%

Day low

Day high

$0.90

$1.06

Open
Open: 0.90

52 week low

52 week high

$0.40

$2.91

Open

Market cap

$12.06M

Average volume

341,531

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.92

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/nrsn

MarketWatch News on NRSN

  1. NeuroSense Therapeutics started at buy with $7.50 stock price target at Alliance Global Partners

    7:26 a.m. July 17, 2023

    - Tomi Kilgore

  2. NeuroSense Therapeutics started at buy with $7 stock price target at Maxim Group

    7:32 a.m. Jan. 7, 2022

    - Tomi Kilgore

/news/nonmarketwatch/company/us/nrsn

Other News on NRSN

No News currently available for NRSN

/news/pressrelease/company/us/nrsn

Press Releases on NRSN

  1. NeuroSense Completes Enrollment in Phase 2b ALS Clinical Trial

    8:05 a.m. May 15, 2023

    - PR Newswire - PRF

  8. NeuroSense CEO Recaps 2022 Achievements & Presents 2023 Catalysts

    8:30 a.m. Feb. 13, 2023

    - PR Newswire - PRF

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.